In vitro and in vivo effects of metformin on human adipose tissue adiponectin

Alessandra Zulian, Raffaella Cancello, Andrea Girola, Luisa Gilardini, Luisella Alberti, Marina Croci, Giancarlo Micheletto, Piergiorgio Danelli, Cecilia Invitti

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: The effects of metformin on adiponectin production are controversial and have never been investigated in human adipose tissue. We analysed whether metformin modulates, in vitro and in vivo, gene expression, protein content, and secretion of adiponectin. Methods: For the in vitro study, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) samples from 5 non-diabetic obese patients were collected. For the in vivo investigation, 22 obese patients were randomly assigned to metformin+lifestyle (ML) or placebo+lifestyle (PL) intervention. SAT specimens and blood samples were collected before and after the intervention in both groups. Results: In in vitro experiments, treatment with metformin increased the expression and secretion of adiponectin in SAT, but not in VAT explants. In the in vivo study, a significant increase in adiponectin and a decreased expression of a macrophage activation marker (CD68) were observed only in SAT of the ML group. Conclusion: These results demonstrate that metformin is able to up-regulate adiponectin gene expression, both in vivo and in vitro, and to stimulate adiponectin protein secretion from human SAT in vitro. It could be hypothesised that metformin-induced adiponectin increase within adipose tissue may have an unexpected role in the reduction of local inflammation.

Original languageEnglish
Pages (from-to)27-33
Number of pages7
JournalObesity Facts
Volume4
Issue number1
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Metformin
Adiponectin
Adipose Tissue
Subcutaneous Fat
activation
Group
Life Style
Intra-Abdominal Fat
experiment
Gene Expression
Macrophage Activation
In Vitro Techniques
Up-Regulation
Placebos
Inflammation
Proteins

Keywords

  • Adiponectin
  • Adipose tissue
  • Insulin resistance
  • Metformin
  • Obesity

ASJC Scopus subject areas

  • Physiology (medical)
  • Health(social science)

Cite this

In vitro and in vivo effects of metformin on human adipose tissue adiponectin. / Zulian, Alessandra; Cancello, Raffaella; Girola, Andrea; Gilardini, Luisa; Alberti, Luisella; Croci, Marina; Micheletto, Giancarlo; Danelli, Piergiorgio; Invitti, Cecilia.

In: Obesity Facts, Vol. 4, No. 1, 02.2011, p. 27-33.

Research output: Contribution to journalArticle

Zulian, Alessandra ; Cancello, Raffaella ; Girola, Andrea ; Gilardini, Luisa ; Alberti, Luisella ; Croci, Marina ; Micheletto, Giancarlo ; Danelli, Piergiorgio ; Invitti, Cecilia. / In vitro and in vivo effects of metformin on human adipose tissue adiponectin. In: Obesity Facts. 2011 ; Vol. 4, No. 1. pp. 27-33.
@article{7a6b2173eae84f4c8e2fe0f416918003,
title = "In vitro and in vivo effects of metformin on human adipose tissue adiponectin",
abstract = "Objective: The effects of metformin on adiponectin production are controversial and have never been investigated in human adipose tissue. We analysed whether metformin modulates, in vitro and in vivo, gene expression, protein content, and secretion of adiponectin. Methods: For the in vitro study, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) samples from 5 non-diabetic obese patients were collected. For the in vivo investigation, 22 obese patients were randomly assigned to metformin+lifestyle (ML) or placebo+lifestyle (PL) intervention. SAT specimens and blood samples were collected before and after the intervention in both groups. Results: In in vitro experiments, treatment with metformin increased the expression and secretion of adiponectin in SAT, but not in VAT explants. In the in vivo study, a significant increase in adiponectin and a decreased expression of a macrophage activation marker (CD68) were observed only in SAT of the ML group. Conclusion: These results demonstrate that metformin is able to up-regulate adiponectin gene expression, both in vivo and in vitro, and to stimulate adiponectin protein secretion from human SAT in vitro. It could be hypothesised that metformin-induced adiponectin increase within adipose tissue may have an unexpected role in the reduction of local inflammation.",
keywords = "Adiponectin, Adipose tissue, Insulin resistance, Metformin, Obesity",
author = "Alessandra Zulian and Raffaella Cancello and Andrea Girola and Luisa Gilardini and Luisella Alberti and Marina Croci and Giancarlo Micheletto and Piergiorgio Danelli and Cecilia Invitti",
year = "2011",
month = "2",
doi = "10.1159/000324582",
language = "English",
volume = "4",
pages = "27--33",
journal = "Obesity Facts",
issn = "1662-4025",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - In vitro and in vivo effects of metformin on human adipose tissue adiponectin

AU - Zulian, Alessandra

AU - Cancello, Raffaella

AU - Girola, Andrea

AU - Gilardini, Luisa

AU - Alberti, Luisella

AU - Croci, Marina

AU - Micheletto, Giancarlo

AU - Danelli, Piergiorgio

AU - Invitti, Cecilia

PY - 2011/2

Y1 - 2011/2

N2 - Objective: The effects of metformin on adiponectin production are controversial and have never been investigated in human adipose tissue. We analysed whether metformin modulates, in vitro and in vivo, gene expression, protein content, and secretion of adiponectin. Methods: For the in vitro study, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) samples from 5 non-diabetic obese patients were collected. For the in vivo investigation, 22 obese patients were randomly assigned to metformin+lifestyle (ML) or placebo+lifestyle (PL) intervention. SAT specimens and blood samples were collected before and after the intervention in both groups. Results: In in vitro experiments, treatment with metformin increased the expression and secretion of adiponectin in SAT, but not in VAT explants. In the in vivo study, a significant increase in adiponectin and a decreased expression of a macrophage activation marker (CD68) were observed only in SAT of the ML group. Conclusion: These results demonstrate that metformin is able to up-regulate adiponectin gene expression, both in vivo and in vitro, and to stimulate adiponectin protein secretion from human SAT in vitro. It could be hypothesised that metformin-induced adiponectin increase within adipose tissue may have an unexpected role in the reduction of local inflammation.

AB - Objective: The effects of metformin on adiponectin production are controversial and have never been investigated in human adipose tissue. We analysed whether metformin modulates, in vitro and in vivo, gene expression, protein content, and secretion of adiponectin. Methods: For the in vitro study, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) samples from 5 non-diabetic obese patients were collected. For the in vivo investigation, 22 obese patients were randomly assigned to metformin+lifestyle (ML) or placebo+lifestyle (PL) intervention. SAT specimens and blood samples were collected before and after the intervention in both groups. Results: In in vitro experiments, treatment with metformin increased the expression and secretion of adiponectin in SAT, but not in VAT explants. In the in vivo study, a significant increase in adiponectin and a decreased expression of a macrophage activation marker (CD68) were observed only in SAT of the ML group. Conclusion: These results demonstrate that metformin is able to up-regulate adiponectin gene expression, both in vivo and in vitro, and to stimulate adiponectin protein secretion from human SAT in vitro. It could be hypothesised that metformin-induced adiponectin increase within adipose tissue may have an unexpected role in the reduction of local inflammation.

KW - Adiponectin

KW - Adipose tissue

KW - Insulin resistance

KW - Metformin

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=79952384985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952384985&partnerID=8YFLogxK

U2 - 10.1159/000324582

DO - 10.1159/000324582

M3 - Article

C2 - 21372608

AN - SCOPUS:79952384985

VL - 4

SP - 27

EP - 33

JO - Obesity Facts

JF - Obesity Facts

SN - 1662-4025

IS - 1

ER -